Trifluoroacetic acid → HCID 46836643, compound
Reaction equation
[S:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[NH:10][C:11]([C:13]1[CH:14]=[CH:15][CH:16]=[C:17]2[C:22]=1[CH2:21][N:20]([C:23]1[S:24][C:25]([CH2:31][CH2:32][CH2:33][O:34][C:35]3[CH:40]=[CH:39][C:38]([NH:41]C(OC(C)(C)C)=O)=[CH:37][CH:36]=3)=[C:26]([C:28]([OH:30])=[O:29])[N:27]=1)[CH2:19][CH2:18]2)=[O:12].C(O)(C(F)(F)F)=O>CO>[NH2:41][C:38]1[CH:37]=[CH:36][C:35]([O:34][CH2:33][CH2:32][CH2:31][C:25]2[S:24][C:23]([N:20]3[CH2:19][CH2:18][C:17]4[C:22](=[C:13]([C:11](=[O:12])[NH:10][C:2]5[S:1][C:5]6[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=6[N:3]=5)[CH:14]=[CH:15][CH:16]=4)[CH2:21]3)=[N:27][C:26]=2[C:28]([OH:30])=[O:29])=[CH:40][CH:39]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound 5-(3-(4-aminophenoxy)propyl)-2-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)thiazole-4-carboxylic acid (6) was prepared by the following procedure: To 2-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-5-(3-(4-(tert-butoxycarbonylamino)phenoxy)propyl)thiazole-4-carboxylic acid (4) (20 mg, 0.029 mmol) in MeOH (1 mL) was added TFA (1 mL, 13 mmol) and stirred at rt for 2 hours. The reaction mixture was purified by HPLC (Preparative reverse phase HPLC was performed on an automated Gilson HPLC system, using a SymmetryPrep Shield RP18 prep cartridge, 250 mm×21.20 mm i.d., 10 um, and a flow rate of 25 mL/min; λ=214, 245 nm; mobile phase A, 0.1% TFA in H2O; mobile phase B, CH3CN; linear gradient 0-70% of B in 40 minutes) to provide the desired product 5-(3-(4-aminophenoxy)propyl)-2-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)thiazole-4-carboxylic acid in 48% yield. 1H NMR (400 MHz, DMSO-d6) δ ppm 12.77 (1H, s), 9.04 (1H, s), 8.03 (1H, d), 7.79 (1H, d), 7.67 (1H, d), 7.47 (2H, m), 7.37 (2H, m), 7.09 (2H, d), 6.92 (2H, m), 4.83 (2H, s), 3.95 (2H, t), 3.72 (2H, t), 3.17 (2H, m), 3.03 (2H, t), 1.99 (2H, m). MS (ESI(+)): m/z 586 (M+H).
Workup
- customThe title compound 5-(3-(4-aminophenoxy)propyl)-2-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)thiazole-4-carboxylic acid (6) was prepared by the following procedure
- customThe reaction mixture was purified by HPLC (Preparative reverse phase HPLC
Sources & evidence
- ORD record
- ord-c50cad303b0343bfb2c96f70f3c0e355
- Source dataset
- uspto-grants-2012_07
- Patent number
- US08232273B2
Reaction notes
Loading…